Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tuberculin Vaccine vs Cryotherapy for Genital Warts
NCT03153566Phase 3Unknown
- Sponsor
- Assiut University
- Start
- Jun 2017
- Primary completion
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, open-label trial of tuberculin purified protein derivative in genital warts (3 arms), sponsored by Assiut University. Primary endpoint: Number of patients with complete resolution of genital warts at 4 months. Status: unknown.
02
Drugs
tuberculin purified protein derivative
03
Conditions
genital warts
Beyond the preview
Go deeper on NCT03153566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03153566.